Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation

We have shown that prostasin serine protease is downregulated in high‐grade prostate tumors and inhibits invasiveness of prostate cancer cell lines upon enforced reexpression. In our study, prostasin mRNA and protein were shown to be expressed in normal human mammary epithelial cells (NHMEC), the poorly invasive breast carcinoma cell line MCF‐7 and the nonmetastatic breast carcinoma cell line MDA‐MB‐453, but absent in highly invasive and metastatic breast carcinoma cell lines MDA‐MB‐231 and MDA‐MB‐435s. Enforced reexpression of prostasin in MDA‐MB‐231 and MDA‐MB‐435s reduced the in vitro invasiveness of either cell line by 50%. Examination of the prostasin gene promoter and first exon revealed a GC‐enriched region that contains transcription regulatory elements. The promoter and exon 1 region of the prostasin gene was investigated for DNA methylation in NHMEC and the carcinoma cell lines. The results revealed a methylation pattern that correlates with prostasin expression in these cells. Demethylation coupled with histone deacetylase inhibition resulted in reactivated expression of the prostasin mRNA in MDA‐MB‐231 and MDA‐MB‐435s cells. These results suggest that prostasin expression in breast cancer cells may be regulated by DNA methylation and that an absence of prostasin expression may contribute to breast cancer invasiveness and metastatic potential. © 2001 Wiley‐Liss, Inc.

[1]  E. Yefenof,et al.  The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice , 2000, Breast Cancer Research and Treatment.

[2]  E. Diamandis,et al.  Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines , 2000, Breast Cancer Research and Treatment.

[3]  N. Greenberg,et al.  Down‐regulation of prostasin serine protease: A potential invasion suppressor in prostate cancer , 2001, The Prostate.

[4]  L. Chao,et al.  Prostasin Is a Glycosylphosphatidylinositol-anchored Active Serine Protease* , 2001, The Journal of Biological Chemistry.

[5]  A. Wolffe,et al.  Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Yao Wang.  The role and regulation of urokinase‐type plasminogen activator receptor gene expression in cancer invasion and metastasis , 2001, Medicinal research reviews.

[7]  H. Tan,et al.  Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo , 2000, Cancer Gene Therapy.

[8]  D. English,et al.  Enhancement of the migration of metastatic human breast cancer cells by phosphatidic acid. , 2000, Biochemical and biophysical research communications.

[9]  A. Wolffe,et al.  DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease. , 2000, Gene expression.

[10]  M. Robinson,et al.  Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. , 1999, Genes & development.

[11]  E. Ballestar,et al.  Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation , 1999, Nature Genetics.

[12]  Paul Tempst,et al.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex , 1999, Nature Genetics.

[13]  A. Bird,et al.  Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. , 1999, Genes & development.

[14]  B. M. Mueller,et al.  Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. , 1999, Experimental cell research.

[15]  J. Dickinson,et al.  Testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lost in testicular germ cell tumors. , 1999, Cancer research.

[16]  M. Duffy,et al.  Urokinase plasminogen activator: A prognostic marker in multiple types of cancer , 1999, Journal of surgical oncology.

[17]  S. Rabbani,et al.  Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: Role of DNA methylation. , 1999, International journal of cancer.

[18]  L. Hood,et al.  Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Theriault,et al.  Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells. , 1999, Clinical & experimental metastasis.

[20]  J. Herman,et al.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.

[21]  D. Wazer,et al.  The role for NES1 serine protease as a novel tumor suppressor. , 1998, Cancer research.

[22]  A. Bird,et al.  Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins , 1998, Molecular and Cellular Biology.

[23]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[24]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[25]  S. Rabbani,et al.  Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies. , 1998, International journal of oncology.

[26]  D. Brown,et al.  Functions of lipid rafts in biological membranes. , 1998, Annual review of cell and developmental biology.

[27]  A. Bird,et al.  MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.

[28]  M. Brattain,et al.  Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7. , 1997, Biochemical and biophysical research communications.

[29]  M. Hendrix,et al.  Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Ward,et al.  Structure and chromosomal localization of the human prostasin (PRSS8) gene. , 1996, Genomics.

[31]  Lee Chao,et al.  Molecular Cloning, Tissue-specific Expression, and Cellular Localization of Human Prostasin mRNA (*) , 1995, The Journal of Biological Chemistry.

[32]  D. Ward,et al.  Molecular cloning, sequence analysis, and chromosomal localization of the human protease inhibitor 4 (kallistatin) gene (PI4). , 1994, Genomics.

[33]  L. Chao,et al.  Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland. , 1994, The Journal of biological chemistry.

[34]  A. Bird,et al.  Effects of DNA methylation on DNA-binding proteins and gene expression. , 1993, Current opinion in genetics & development.

[35]  D. Rifkin,et al.  Biology and biochemistry of proteinases in tumor invasion. , 1993, Physiological reviews.

[36]  M. Boyle,et al.  Presence of single-stranded DNA in PCR products of slow electrophoretic mobility. , 1992, BioTechniques.

[37]  A. Bird,et al.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA , 1992, Cell.

[38]  J. Price,et al.  Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. , 1990, Cancer research.

[39]  H. Adlercreutz.  Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. , 1990, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[40]  A. Bird,et al.  Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs , 1989, Cell.

[41]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.